Why the study?
Does elevated preoperative platelet count or platelet-lymphocyte ratio predict worse survival in patients with colorectal cancer and hepatic metastasis?
Population
454 patients, comprising 336 with colorectal cancer (CRC) and 118 with hepatic metastasis of CRC (mCRC)
Design
Cohort
Follow-up
10 years (retrospective data collection period)
Authors
Loading...
May aid preoperative risk stratification in CRC; Level 3 data leaves open clinical adoption pending prospective validation.
Does elevated preoperative platelet count or platelet-lymphocyte ratio predict worse survival in patients with colorectal cancer and hepatic metastasis?
Elevated preoperative platelet count, but not platelet-lymphocyte ratio, serves as an independent prognostic marker for worse survival in patients with colorectal cancer and its hepatic metastases.
Krzystanek et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: